Update on the pharmacotherapy of cerebellar and central vestibular disorders
Modern pharmacotherapy for central vestibular syndromes and cerebellar disorders is actively evolving and includes new medications aimed at improving coordination, reducing nystagmus, and normalizing cerebellar function. Some have already shown effectiveness in clinical studies, while new therapies continue to be investigated in international trials.
